Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration

Autoria(s): Doggrell, Sheila
Data(s)

2005
Identificador

http://eprints.qut.edu.au/44928/
Publicador

Informa Healthcare
Relação

DOI:10.1517/14656566.6.8.1421

Doggrell, Sheila (2005) Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion on Pharmacotherapy, 6(8), pp. 1421-1423.
Palavras-Chave #060100 BIOCHEMISTRY AND CELL BIOLOGY #060500 MICROBIOLOGY #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES
Tipo

Journal Article
Acesso ao item digital